CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized the field of genomics, enabling precise editing of DNA sequences. Recent discoveries have revealed that CRISPR enzymes Cas-12 and Cas-13 can also serve as powerful diagnostic tools. The utilization of CRISPR Cas-12 and Cas-13-based methods for disease detection has the potential to revolutionize the field of diagnostics, offering rapid and accurate disease identification and greatly enhancing patient outcomes.
This Methods Collection aims to delve into the vast potential of CRISPR Cas-12 and Cas-13-based methods for disease detection and provide a roadmap for future research in this area. The primary objective is to provide a comprehensive overview of the current state of CRISPR Cas-12 and Cas-13-based disease detection methods. The collection will encompass discussions on the advantages and limitations of these methods, shedding light on their unique features. Additionally, the articles will outline promising avenues for further research by exploring the potential applications of CRISPR Cas-12 and Cas-13-based methods in clinical settings.
0 Views
•
2025
•
0 Views
•
Cited by 3
•
2024
•
Bo Wang*1,2, Yu-zhao Xu*1, Yun-chao Zhou1, Shan Ha1, Xiao-shi Qin1, Jie Cai1,2, Bin Cong1,3, Jian-hua Chen1, Jian-qiang Deng1
1Hainan Province Tropical Forensic Engineering Research Center, Department of Forensic Medicine, Hainan Medical University, Hainan Provincial Academician Workstation (tropical forensic medicine), 2Hainan Vocational College of Political Science and Law, Hainan Gongping Forensic Center, 3Department of Forensic Medicine, Hebei Medical University